^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dexamethasone injection

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Steroid receptor agonist, GCR agonist
    Related drugs:
    Associations

    News

    Trials
    1d
    Real MM: STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA (clinicaltrials.gov)
    P4, N=450, Active, not recruiting, University of Turin, Italy | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    lenalidomide • bortezomib • prednisone • melphalan • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    9d
    The Effect of Dexamethasone Administration Route in Pediatric Brachial Plexus Block (clinicaltrials.gov)
    P4, N=90, Recruiting, Poznan University of Medical Sciences | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone injection
    10d
    ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma (clinicaltrials.gov)
    P2, N=160, Not yet recruiting, Massachusetts General Hospital
    New P2 trial
    |
    clonoSEQ
    |
    lenalidomide • bortezomib • Elrexfio (elranatamab-bcmm) • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    14d
    Intraoperative and Postoperative Effects of Tramadol and Dexamethasone Added to Washing Solution in Knee Arthroscopies (clinicaltrials.gov)
    P=N/A, N=80, Active, not recruiting, Yuzuncu Yil University | Not yet recruiting --> Active, not recruiting
    Enrollment closed
    |
    dexamethasone injection
    15d
    Dexamethasone Regimens for BPD Prevention in Preterm Infants (clinicaltrials.gov)
    P3, N=970, Not yet recruiting, The Children's Hospital of Zhejiang University School of Medicine | Initiation date: Jul 2025 --> Feb 2026
    Trial initiation date
    |
    dexamethasone injection
    17d
    Comparison of Pain Between Supraperiosteal Injection of Dexamethasone Versus Placebo on Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis (clinicaltrials.gov)
    P=N/A, N=44, Active, not recruiting, College of Physicians and Surgeons Pakistan
    New trial
    |
    dexamethasone injection
    17d
    QLM2010-301: To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. (clinicaltrials.gov)
    P3, N=665, Completed, Qilu Pharmaceutical Co., Ltd. | Recruiting --> Completed | Trial completion date: Mar 2026 --> Oct 2025 | Trial primary completion date: Dec 2025 --> Aug 2025
    Trial completion • Trial completion date • Trial primary completion date
    |
    dexamethasone injection • fosaprepitant
    18d
    Pulsed Radiofrequency Ablation and Steroid Injections for the Treatment of Meralgia Paresthetica (clinicaltrials.gov)
    P=N/A, N=22, Completed, Ankara City Hospital Bilkent | Active, not recruiting --> Completed
    Trial completion
    |
    dexamethasone injection
    21d
    Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial (clinicaltrials.gov)
    P1/2, N=10, Active, not recruiting, University of Southern California | Recruiting --> Active, not recruiting | N=42 --> 10
    Enrollment closed • Enrollment change
    |
    Keytruda (pembrolizumab) • bortezomib • Reolysin (pelareorep) • Hemady (dexamethasone tablets) • dexamethasone injection
    25d
    AQUARIUS: A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis (clinicaltrials.gov)
    P2, N=151, Active, not recruiting, Janssen Research & Development, LLC | Trial primary completion date: Mar 2026 --> May 2025
    Trial primary completion date
    |
    bortezomib • cyclophosphamide • Darzalex Faspro (daratumumab and hyaluronidase-fihj) • dexamethasone injection
    1m
    SINE: Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov)
    P1, N=52, Completed, University of Chicago | Recruiting --> Completed | N=100 --> 52 | Trial completion date: Dec 2026 --> Oct 2025 | Trial primary completion date: Jul 2026 --> Oct 2025
    Trial completion • Enrollment change • Trial completion date • Trial primary completion date
    |
    CRBN (Cereblon)
    |
    Xpovio (selinexor) • carfilzomib • dexamethasone injection
    1m
    Dexamethasone-Ondansetron Combined with Diphenhydramine for Preventing Postoperative Nausea and Vomiting in Thoracoscopic lung surgery: A double blind randomized controlled trial (ChiCTR2500110881)
    P=N/A, N=200, Not yet recruiting, Anesthesia and Surgery Center of West China Hospital Sichuan University; West China Hospital Sichuan University
    New trial
    |
    dexamethasone injection • ondansetron intravenous